Welcome to the VC Round-up, where we’ll parse through venture capital news related to Philadelphia-based private equity firms and the companies they fund. Subscribe to the roundup as an email newsletter. If you have any VC-related news to pass along to us, please drop us a line.
DEFINITE READS
According to SEC filings, WizeHive, the cloud-based business applications startup founded by Dreamit partner Michael Leveinson, has just closed a $950,000 round of funding. Maybe it’s the reason the business can offer $250,000 in grants?
The Wall Street Journal reports that Emerald Stage2 Ventures has about $5 million remaining in its current fund.
MIGHT BE WORTH YOUR TIME
Tranzyme Pharma, a Quaker BioVentures company is having some trouble with its IPO. The company initially planned to offer shares at around $12 per share, but had to revise its forecasts to $4 per share. According to MarketWatch, this is the fifth time out of five that a biotech company has struggled in its IPO this year.
According to the Inky, Safeguard Scientifics is investing $25 million in PixelOptics. The company, based in Virginia, targets people with presbyopia, a condition in which the eye’s ability to focus on near objects worsens with age.
GIVE A GLANCE
First Round Capital has continued its investment in Kno a educational software company. Also investing were Intel and Andreessen Horowitz.
Lots of folks have been telling us that we shouldn’t sleep on Lehigh University as a leading entrepreneur university and here’s just another reason why: the University has landed Matt Bieber of Originate Ventures as an adjunct.
Before you go...
Please consider supporting Technical.ly to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.
Join our growing Slack community
Join 5,000 tech professionals and entrepreneurs in our community Slack today!